To further determine which population of T cells is more important in controlling AMPK-mediated anti-tumor effect, as previously described [28], we depleted the CD4+ or CD8+ population with the respective neutralizing antibodies in mice (Supplementary Figure 2D), and compared tumor growth among depletion and non-depletion groups. The gene discussed is PRKAA1; the disease is neoplasm.